These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 29907945

  • 1. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A, Pilger D, Cordini D, Seibel I, Riechardt AI, Joussen AM, Bechrakis NE.
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [Abstract] [Full Text] [Related]

  • 2. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
    Willerding GD, Cordini D, Moser L, Krause L, Foerster MH, Bechrakis NE.
    Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
    Barker CA, Francis JH, Cohen GN, Marr BP, Wolden SL, McCormick B, Abramson DH.
    Brachytherapy; 2014 Apr; 13(6):584-90. PubMed ID: 24880583
    [Abstract] [Full Text] [Related]

  • 6. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L, Wackernagel W, Avian A, Mayer C, Schneider M, Winkler P, Langmann G.
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [Abstract] [Full Text] [Related]

  • 7. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM.
    Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjunctive plaque radiotherapy after local resection of uveal melanoma.
    Damato B.
    Front Radiat Ther Oncol; 1997 Nov; 30():123-32. PubMed ID: 9205892
    [No Abstract] [Full Text] [Related]

  • 10. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D, Dürr C, Paulsen F, Kaulich T, Bartz-Schmidt KU.
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [Abstract] [Full Text] [Related]

  • 11. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM, Tagliaferri L, Azario L, Lenkowicz J, Lanza A, Autorino R, Caputo CG, Gambacorta MA, Valentini V, Blasi MA.
    Brachytherapy; 2018 Dec; 17(2):432-438. PubMed ID: 29275868
    [Abstract] [Full Text] [Related]

  • 12. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V, Mehta MP.
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [Abstract] [Full Text] [Related]

  • 13. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe'er J.
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [Abstract] [Full Text] [Related]

  • 14. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
    Puusaari I, Damato B, Kivelä T.
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Seibel I, Riechardt AI, Heufelder J, Cordini D, Joussen AM.
    Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P, Fiorica F, D'Angelo S, Lamberti G, Parmeggiani F, Martini A, Carpenteri F, Colosimo C, Micucci M, Perazzini L, De Gugliemo E, Berretta M, Sebastiani A, Cartei F.
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [Abstract] [Full Text] [Related]

  • 18. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
    Pe'er J, Stefani FH, Seregard S, Kivela T, Lommatzsch P, Prause JU, Sobottka B, Damato B, Chowers I.
    Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
    [Abstract] [Full Text] [Related]

  • 19. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    King B, Morales-Tirado VM, Wynn HG, Gao BT, Ballo MT, Wilson MW.
    Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
    [Abstract] [Full Text] [Related]

  • 20. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, Freire J.
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.